BIRC5 and hepatocellular carcinoma: Additionally, Wan et al. achieved specific recognition and binding of the nanocarrier to the asialoglycoprotein receptor (ASGPR) on the surface of hepatocellular carcinoma (HCC) cells by modifying the surface of the metal–organic framework (MOF) with N-acetylgalactosamine (GalNAc), thereby enabling efficient delivery of survivin siRNA.